The Phosphodiesterase 3 Inhibitor Cilostazol as an Adjunct to Conventional Therapy in Patients With Osteoarthritis
Condition: Osteoarthritis Interventions: Drug: Cilostazol 50 MG; Drug: Placebo Sponsor: Sadat City University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - March 10, 2021 Category: Research Source Type: clinical trials
